CUSIP: 19188J300
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,210,092
-
Share change
-
-135,339
-
Total reported value
-
$5,824,410
-
Price per share
-
$0.41
-
Number of holders
-
26
-
Value change
-
-$65,031
-
Number of buys
-
7
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 19188J300?
CUSIP 19188J300 identifies COCP - COCRYSTAL PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 19188J300:
Institutional Holders of COCRYSTAL PHARMA INC - COM (COCP) as of Q2 2022
As of 30 Jun 2022,
COCRYSTAL PHARMA INC - COM (COCP) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,210,092 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, Parallel Advisors, LLC, Verition Fund Management LLC, and NORTHERN TRUST CORP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.